Takeda Pharmaceutical Co. (TAK)
(Real Time Quote from BATS)
$15.06 USD
+0.04 (0.27%)
Updated Sep 19, 2025 09:30 AM ET
5-Strong Sell of 5 5
B Value C Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, Takeda Pharmaceutical Co. has a market cap of $47.79B, which represents its share price of $15.02 multiplied by its outstanding shares number of 3.18B. As a large-cap company, TAK's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TAK 15.06 +0.04(0.27%)
Will TAK be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TAK based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TAK
KALV Stock Moves More Than 30% in a Week: What Is Driving This Rally?
Will Strong Asceniv Sales Drive ADMA Biologics Further?
TAK: What are Zacks experts saying now?
Zacks Private Portfolio Services
Ocular Therapeutix (OCUL) Moves 8.6% Higher: Will This Strength Last?
ADMA vs Takeda: Which Plasma Therapy Stock Is the Better Buy Today?
ADMA Looks to Expand Asceniv's Label: Will This Boost Sales?
Other News for TAK
Is TAK set to breakout? NR7 shows up after sliding 0.46%
Is TAK positioned for a breakdown? 20 Day Moving Average Resistance shows up after declining 0.2%
Novavax: Endlessly Frustrating, Endlessly Fascinating - Warrants Rating Upgrade
TAK forms NR7 on September 16
Takeda Flat on Hookup with VELA